Ignite Creation Date:
2025-12-24 @ 11:49 AM
Ignite Modification Date:
2026-01-01 @ 3:02 AM
Study NCT ID:
NCT05810961
Status:
TERMINATED
Last Update Posted:
2024-11-22
First Post:
2023-03-29
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Assess Effectiveness and Safety of Efgartigimod in Chinese Patients with Primary Membranous Nephropathy (ZL-1103-014)
Sponsor:
argenx
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-02-20
Start Date Type:
ACTUAL
Primary Completion Date:
2024-08-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-08-05
Completion Date Type:
ACTUAL
First Submit Date:
2023-03-29
First Submit QC Date:
None
Study First Post Date:
2023-04-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-11-20
Last Update Post Date:
2024-11-22
Last Update Post Date Type:
ACTUAL